149 related articles for article (PubMed ID: 12807155)
41. Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing.
Hongo T; Okada S; Inoue N; Yamada S; Yajima S; Watanabe C; Fujii Y; Horikoshi Y
Int J Hematol; 2002 Oct; 76(3):251-9. PubMed ID: 12416736
[TBL] [Abstract][Full Text] [Related]
42. BCR-ABL rearrangement in a child with acute myelogenous leukaemia without a Philadelphia chromosome.
Borkhardt A; Repp R; Harbott J; Lakomek M; Janssen JW; Schlieben S; Bartram CR; Lampert F
Br J Haematol; 1993 Jun; 84(2):341-2. PubMed ID: 8398840
[TBL] [Abstract][Full Text] [Related]
43. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.
Den Boer ML; van Slegtenhorst M; De Menezes RX; Cheok MH; Buijs-Gladdines JG; Peters ST; Van Zutven LJ; Beverloo HB; Van der Spek PJ; Escherich G; Horstmann MA; Janka-Schaub GE; Kamps WA; Evans WE; Pieters R
Lancet Oncol; 2009 Feb; 10(2):125-34. PubMed ID: 19138562
[TBL] [Abstract][Full Text] [Related]
44. Src kinases as targets for B cell acute lymphoblastic leukaemia therapy.
Li S
Expert Opin Ther Targets; 2005 Apr; 9(2):329-41. PubMed ID: 15934919
[TBL] [Abstract][Full Text] [Related]
45. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Ito C; Evans WE; McNinch L; Coustan-Smith E; Mahmoud H; Pui CH; Campana D
J Clin Oncol; 1996 Aug; 14(8):2370-6. PubMed ID: 8708730
[TBL] [Abstract][Full Text] [Related]
46. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.
Yan J; Jiang N; Huang G; Tay JL; Lin B; Bi C; Koh GS; Li Z; Tan J; Chung TH; Lu Y; Ariffin H; Kham SK; Yeoh AE; Chng WJ
Br J Haematol; 2013 Oct; 163(1):93-103. PubMed ID: 23888996
[TBL] [Abstract][Full Text] [Related]
47. Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia.
Tosi P; Visani G; Ottaviani E; Manfroi S; Tura S
Eur J Haematol; 1996 Aug; 57(2):134-41. PubMed ID: 8856090
[TBL] [Abstract][Full Text] [Related]
48. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia.
Roberts WM; Rivera GK; Raimondi SC; Santana VM; Sandlund JT; Crist WM; Pui CH
Lancet; 1994 Feb; 343(8893):331-2. PubMed ID: 7905148
[TBL] [Abstract][Full Text] [Related]
49. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
Pieters R; Huismans DR; Loonen AH; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
Lancet; 1991 Aug; 338(8764):399-403. PubMed ID: 1678081
[TBL] [Abstract][Full Text] [Related]
50. Detection of BCR/ABL transcripts by reverse transcriptase polimerase chain reaction in pediatric acute Lymphoblastic Leukemia: ıncidence and clinical eatures.
Sarper N; Özbek U; Ağaoğlu L; Özgen Ü; Kandilci A; Sırma S; Anak S; Yalman N; Eryılmaz E; Devecioğlu Ö; Gedikoğlu G
Turk J Haematol; 2000 Dec; 17(4):197-206. PubMed ID: 27263637
[TBL] [Abstract][Full Text] [Related]
51. Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance.
Wong NC; Bhadri VA; Maksimovic J; Parkinson-Bates M; Ng J; Craig JM; Saffery R; Lock RB
BMC Genomics; 2014 Jun; 15(1):416. PubMed ID: 24885906
[TBL] [Abstract][Full Text] [Related]
52. Multi-Lineage
Nishiwaki S; Kim JH; Ito M; Maeda M; Okuno Y; Koyama D; Ozawa Y; Gunji M; Osaki M; Kitamura K; Ushijima Y; Ishikawa Y; Miyamura K; Sugiura I; Kiyoi H
Front Oncol; 2020; 10():586567. PubMed ID: 33194739
[TBL] [Abstract][Full Text] [Related]
53. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.
Kaspers GJ; Smets LA; Pieters R; Van Zantwijk CH; Van Wering ER; Veerman AJ
Blood; 1995 Feb; 85(3):751-6. PubMed ID: 7833478
[TBL] [Abstract][Full Text] [Related]
54. In vitro drug sensitivity and expression profiling for disease prognostication in childhood acute lymphoblastic leukaemia (ALL): an exploratory model using cell lines.
Liu XG; Chen SP; Kham SK; Quah TC; Yeoh AE
Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S21-2. PubMed ID: 15651190
[No Abstract] [Full Text] [Related]
55. Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response.
Sassen SDT; Mathôt RAA; Pieters R; de Haas V; Kaspers GJL; van den Bos C; Tissing WJE; Te Loo DMWW; Bierings MB; van der Sluis IM; Zwaan CM
Br J Haematol; 2021 Jul; 194(2):423-432. PubMed ID: 34060065
[TBL] [Abstract][Full Text] [Related]
56. In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.
Ramakers-van Woerden NL; Pieters R; Slater RM; Loonen AH; Beverloo HB; van Drunen E; Heyman M; Moreno TC; Rots MG; van Wering ER; Kamps WA; Janka-Schaub GE; Veerman AJ
Br J Haematol; 2001 Mar; 112(3):680-90. PubMed ID: 11260073
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R
Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318
[TBL] [Abstract][Full Text] [Related]
58. Mixed phenotype acute leukaemia with t(9,22), BCR-ABL1: A case report.
Yong WL; Yusof N; Ithnin A; Shuib S; Tumian R; Yousuf R; Abdul Aziz S
Malays J Pathol; 2020 Dec; 42(3):469-476. PubMed ID: 33361731
[TBL] [Abstract][Full Text] [Related]
59. In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.
Kaspers GJ; Pieters R; Van Zantwijk CH; De Laat PA; De Waal FC; Van Wering ER; Veerman AJ
Br J Cancer; 1991 Sep; 64(3):469-74. PubMed ID: 1911186
[TBL] [Abstract][Full Text] [Related]
60. BCR-ABL Translocation in Pediatric Acute Lymphoblastic Leukemia in Southern India.
Sugapriya D; Preethi S; Shanthi P; Chandra N; Jeyaraman G; Sachdanandam P; Thilagavathy S; Venkatadesilalu S
Indian J Hematol Blood Transfus; 2012 Mar; 28(1):37-41. PubMed ID: 23449388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
